Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for COVID-19 saliva collection kits. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global COVID-19 saliva collection kits market from 2025 to 2032.
Key Insights:
• COVID-19 Saliva Collection Kits Market Size (2025E): US$204.7 Million
• Projected Market Value (2032F): US$251.8 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 3.0%
COVID-19 Saliva Collection Kits Market - Report Scope:
COVID-19 saliva collection kits are diagnostic sample collection solutions designed to obtain saliva specimens for the detection of SARS-CoV-2 infections. These kits provide a non-invasive, convenient, and safer alternative to traditional nasopharyngeal and oropharyngeal swab testing methods. The market includes PCR-based kits, rapid test kits, and saliva collection devices integrated with advanced molecular diagnostic technologies such as RT-qPCR, direct sample-to-PCR workflows, and lateral flow assays. These solutions are widely utilized across diagnostic laboratories, hospitals, clinics, research institutions, workplaces, schools, and home-testing environments. Market growth is supported by the increasing preference for user-friendly testing methods, reduced transmission risks during sample collection, and ongoing surveillance requirements for infectious disease monitoring.
Market Growth Drivers:
The global COVID-19 saliva collection kits market is propelled by several key factors, including the growing demand for non-invasive and patient-friendly diagnostic testing solutions. Saliva-based testing minimizes discomfort compared to nasal swabs while enabling easier self-collection and large-scale screening programs. Increasing adoption of saliva-based PCR testing across schools, workplaces, airports, and community health programs continues to drive market demand. Technological advancements in RT-qPCR and direct sample-to-PCR testing workflows have improved diagnostic accuracy, sensitivity, and turnaround times. Furthermore, regulatory approvals for saliva-based diagnostic tests and growing awareness regarding home-based testing solutions have expanded accessibility and consumer acceptance across multiple healthcare settings.
Market Restraints:
Despite promising growth prospects, the COVID-19 saliva collection kits market faces challenges related to declining pandemic-driven testing demand and the transition from emergency response measures to endemic disease management. Reduced government procurement programs and lower testing volumes in several regions may constrain long-term market growth. Variability in saliva sample quality, differences in collection protocols, and concerns regarding diagnostic consistency compared to traditional swab-based testing can also create adoption barriers. Additionally, evolving regulatory requirements and reimbursement limitations may affect commercialization strategies for diagnostic manufacturers. Supply chain disruptions and pricing pressures further contribute to operational challenges within the market.
Market Opportunities:
The COVID-19 saliva collection kits market presents significant growth opportunities driven by the development of advanced diagnostic assays and expanded infectious disease testing applications. Manufacturers are increasingly investing in multiplex testing platforms capable of detecting multiple respiratory pathogens from a single saliva sample, broadening market relevance beyond COVID-19 diagnostics. The growing adoption of at-home testing kits, self-collection programs, and digital health integration offers additional growth potential. Furthermore, public health surveillance initiatives, workplace monitoring programs, and school-based screening efforts continue to create demand for scalable saliva collection solutions. Innovations in simplified collection methods, improved assay sensitivity, and rapid processing technologies are expected to support future market expansion.
Key Questions Answered in the Report:
• What are the primary factors driving the growth of the COVID-19 saliva collection kits market globally?
• Which product categories and diagnostic technologies are accelerating adoption across healthcare and public health settings?
• How are technological advancements reshaping the competitive landscape of the COVID-19 saliva collection kits market?
• Who are the key players contributing to the COVID-19 saliva collection kits market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global COVID-19 saliva collection kits market?
Competitive Intelligence and Business Strategy:
Leading players in the global COVID-19 saliva collection kits market, including Thermo Fisher Scientific, Qiagen, and Takara Bio Inc., focus on diagnostic innovation, assay sensitivity enhancement, and strategic collaborations to strengthen their market position. Companies are investing in next-generation saliva-based molecular testing platforms, direct-to-consumer diagnostic solutions, and automated sample processing technologies to improve testing efficiency and accessibility. Partnerships with healthcare providers, diagnostic laboratories, public health agencies, and research institutions continue to support market expansion and product validation. Additionally, manufacturers are emphasizing user-friendly home collection kits, rapid turnaround solutions, and multiplex pathogen detection capabilities to diversify revenue streams beyond COVID-19 testing alone.
Key Companies Profiled:
• Qiagen
• Thermo Fisher Scientific
• Takara Bio Inc.
• Hologic
• GeneProof
• Arcis Biotechnology Limited
• Kolplast Group
• Abacus ALS
• Vitagene
• ACON Laboratories, Inc.
• Therma Bright Inc.
• Assure Tech. (Hangzhou) Co., Ltd.
• Zymo Research Corporation
• Kyodo International Inc.
• Salimetrics
COVID-19 Saliva Collection Kits Market Research Segmentation:
The COVID-19 saliva collection kits market encompasses a broad range of product types, diagnostic technologies, end-user categories, and regional markets supporting large-scale infectious disease testing and surveillance initiatives.
By Product Type:
• Rapid Test Kits
• PCR-based Kits
By Technology:
• Direct Sample-to-PCR
• RT-qPCR
• Lateral Flow Assays
By End-User:
• Diagnostic Laboratories
• Hospitals & Clinics
• Research Institutes
• Home Testing & Self-Care Users
• Workplaces
• Educational Institutions
• Others
By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global COVID-19 Saliva Collection Kits Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Chain Analysis
3.1. Supply Chain Analysis
3.2. List of Key Market Players
4. Value Added Insights
4.1. PESTLE Analysis
4.2. Porter’s Five Force Analysis
5. Price Trend Analysis, 2019 - 2032
5.1. Pricing Analysis, By Product Type
5.2. Key Factors Impacting Prices, By Technology
6. Global COVID-19 Saliva Collection Kits Market Outlook
6.1. Key Highlights
6.1.1. Market Size (US$ Mn) and Y-o-Y Growth
6.1.2. Absolute $ Opportunity
6.2. Market Size (US$ Mn) Analysis and Forecast
6.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
6.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
6.3. Global COVID-19 Saliva Collection Kits Market Outlook: Product Type
6.3.1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
6.3.2. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
6.3.2.1. Rapid Test Kits
6.3.2.2. PCR-based Kits
6.3.3. Market Attractiveness Analysis: Product Type
6.4. Global COVID-19 Saliva Collection Kits Market Outlook: Technology
6.4.1. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2024
6.4.2. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
6.4.2.1. Direct Sample to PCR
6.4.2.2. RT-qPCR
6.4.2.3. Lateral Flow Assays
6.4.3. Market Attractiveness Analysis: Technology
6.5. Global COVID-19 Saliva Collection Kits Market Outlook: End-user
6.5.1. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
6.5.2. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
6.5.2.1. Diagnostic Laboratories
6.5.2.2. Hospitals and Clinics
6.5.2.3. Academic and Research Institutes
6.5.2.4. Biopharma Companies
6.5.2.5. Long Term Care Facilities
6.5.2.6. Home Care Settings
6.5.2.7. Others
6.5.3. Market Attractiveness Analysis: End-user
7. Global COVID-19 Saliva Collection Kits Market Outlook: Region
7.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
7.2. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
7.2.1. North America
7.2.2. Europe
7.2.3. East Asia
7.2.4. South Asia and Oceania
7.2.5. Latin America
7.2.6. Middle East & Africa
7.3. Market Attractiveness Analysis: Region
8. North America COVID-19 Saliva Collection Kits Market Outlook
8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Product Type
8.1.3. By Technology
8.1.4. By End-user
8.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
8.2.1. U.S.
8.2.2. Canada
8.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
8.3.1. Rapid Test Kits
8.3.2. PCR-based Kits
8.4. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
8.4.1. Direct Sample to PCR
8.4.2. RT-qPCR
8.4.3. Lateral Flow Assays
8.5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
8.5.1. Diagnostic Laboratories
8.5.2. Hospitals and Clinics
8.5.3. Academic and Research Institutes
8.5.4. Biopharma Companies
8.5.5. Long Term Care Facilities
8.5.6. Home Care Settings
8.5.7. Others
8.6. Market Attractiveness Analysis
9. Europe COVID-19 Saliva Collection Kits Market Outlook
9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Product Type
9.1.3. By Technology
9.1.4. By End-user
9.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
9.2.1. Germany
9.2.2. France
9.2.3. U.K.
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Türkiye
9.2.8. Rest of Europe
9.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
9.3.1. Rapid Test Kits
9.3.2. PCR-based Kits
9.4. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
9.4.1. Direct Sample to PCR
9.4.2. RT-qPCR
9.4.3. Lateral Flow Assays
9.5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
9.5.1. Diagnostic Laboratories
9.5.2. Hospitals and Clinics
9.5.3. Academic and Research Institutes
9.5.4. Biopharma Companies
9.5.5. Long Term Care Facilities
9.5.6. Home Care Settings
9.5.7. Others
9.6. Market Attractiveness Analysis
10. East Asia COVID-19 Saliva Collection Kits Market Outlook
10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Product Type
10.1.3. By Technology
10.1.4. By End-user
10.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
10.3.1. Rapid Test Kits
10.3.2. PCR-based Kits
10.4. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
10.4.1. Direct Sample to PCR
10.4.2. RT-qPCR
10.4.3. Lateral Flow Assays
10.5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
10.5.1. Diagnostic Laboratories
10.5.2. Hospitals and Clinics
10.5.3. Academic and Research Institutes
10.5.4. Biopharma Companies
10.5.5. Long Term Care Facilities
10.5.6. Home Care Settings
10.5.7. Others
10.6. Market Attractiveness Analysis
11. South Asia & Oceania COVID-19 Saliva Collection Kits Market Outlook
11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Product Type
11.1.3. By Technology
11.1.4. By End-user
11.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
11.2.1. India
11.2.2. Southeast Asia
11.2.3. ANZ
11.2.4. Rest of South Asia & Oceania
11.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
11.3.1. Rapid Test Kits
11.3.2. PCR-based Kits
11.4. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
11.4.1. Direct Sample to PCR
11.4.2. RT-qPCR
11.4.3. Lateral Flow Assays
11.5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
11.5.1. Diagnostic Laboratories
11.5.2. Hospitals and Clinics
11.5.3. Academic and Research Institutes
11.5.4. Biopharma Companies
11.5.5. Long Term Care Facilities
11.5.6. Home Care Settings
11.5.7. Others
11.6. Market Attractiveness Analysis
12. Latin America COVID-19 Saliva Collection Kits Market Outlook
12.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Product Type
12.1.3. By Technology
12.1.4. By End-user
12.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
12.2.1. Brazil
12.2.2. Mexico
12.2.3. Rest of Latin America
12.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
12.3.1. Rapid Test Kits
12.3.2. PCR-based Kits
12.4. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
12.4.1. Direct Sample to PCR
12.4.2. RT-qPCR
12.4.3. Lateral Flow Assays
12.5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
12.5.1. Diagnostic Laboratories
12.5.2. Hospitals and Clinics
12.5.3. Academic and Research Institutes
12.5.4. Biopharma Companies
12.5.5. Long Term Care Facilities
12.5.6. Home Care Settings
12.5.7. Others
12.6. Market Attractiveness Analysis
13. Middle East & Africa COVID-19 Saliva Collection Kits Market Outlook
13.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
13.1.1. By Country
13.1.2. By Product Type
13.1.3. By Technology
13.1.4. By End-user
13.2. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
13.2.1. GCC Countries
13.2.2. Egypt
13.2.3. South Africa
13.2.4. Northern Africa
13.2.5. Rest of Middle East & Africa
13.3. Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
13.3.1. Rapid Test Kits
13.3.2. PCR-based Kits
13.4. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
13.4.1. Direct Sample to PCR
13.4.2. RT-qPCR
13.4.3. Lateral Flow Assays
13.5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
13.5.1. Diagnostic Laboratories
13.5.2. Hospitals and Clinics
13.5.3. Academic and Research Institutes
13.5.4. Biopharma Companies
13.5.5. Long Term Care Facilities
13.5.6. Home Care Settings
13.5.7. Others
13.6. Market Attractiveness Analysis
14. Competition Landscape
14.1. Market Share Analysis, 2025
14.2. Market Structure
14.2.1. Competition Intensity Mapping By Market
14.2.2. Competition Dashboard
14.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
14.3.1. Qiagen
14.3.1.1. Overview
14.3.1.2. Segments and Product Type
14.3.1.3. Key Financials
14.3.1.4. Market Developments
14.3.1.5. Market Strategy
14.3.2. Thermo Fisher Scientific
14.3.3. Takara Bio Inc.
14.3.4. Hologic
14.3.5. GeneProof
14.3.6. Arcis Biotechnology Limited
14.3.7. Kolplast Group
14.3.8. Abacus ALS
14.3.9. Vitagene
14.3.10. ACON Laboratories, Inc.
14.3.11. Therma Bright Inc.
14.3.12. Assure Tech. (Hangzhou) Co., Ltd.
14.3.13. Zymo Research Corporation
14.3.14. Kyodo International Inc.
14.3.15. Salimetrics
14.3.16. Others
15. Appendix
15.1. Research Methodology
15.2. Research Assumptions
15.3. Acronyms and Abbreviations